CoronaryAtlas logo
CoronaryAtlas
Vimentin
Pathway / Platelet adhesion & activation

Vimentin

VIMprotein

Vimentin is released from the platelet cytoskeleton during activation and reflects both platelet involvement and vascular inflammation.

Pathway placement
Cascade stepPlatelet adhesion & activation
Confidencemedium
RationaleIntermediate filament in platelet cytoskeleton; released during activation.
Also acts inMyocardial injury, Vascular inflammation, Endothelial activation/erosion
Druggability
DruggableYes
Known drugs / candidates1
Small-molecule tractableYes
Antibody tractableYes
EnsemblENSG00000026025

Type I vs Type II discrimination

ScoresType-II-associated
R — rupture / Type-I
—
C — confounder / Type-II
58
A — assay feasibility
72
E — evidence strength
31
T1DI (composite)
6
Specificity differential (R−C)-43
Confounder panel (Type-II drivers)
1sepsis / systemic inflammationmag 2
2anemia / acute blood lossn/a
3hypovolemia / dehydrationn/a
4tachyarrhythmiamag 2
5hypoxemia / respiratory failuremag 2
6hypertensive emergencyn/a
7high-demand / peri-operative stressmag 1
Coverage: 4/7 confounders with evidence
Tier: deep-scored (abstract-extracted) · 8 supporting references. See the discrimination table for all markers.

Assay & specimen

Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Serum or plasma
Collection tube
Serum separator (gold/red-top, SST) · K2/K3-EDTA (lavender-top)
Method / principle
Sandwich immunoassay (ELISA) — research-grade unless a cleared assay exists
Reagent / substrate
Matched anti-target antibody pair (capture + labeled detection)
Platform
ELISA microplate or multiplex (Luminex/MSD)
Turnaround · availability
Send-out / research · Research-grade (no universal clinical assay)

Literature evidence(4)